Barbara Duncan

Barbara Duncan is an experienced board member and leader in the pharmaceutical and biotechnology sectors, currently serving as a board member for Halozyme, Inc., and Atea Pharmaceuticals, Inc., and as chairperson for Fusion Pharmaceuticals until June 2024. With a history of board membership at various organizations including Versanis Bio, Adaptimmune, Jounce Therapeutics, and ObsEva SA, Barbara has demonstrated a strong commitment to corporate governance and strategic oversight. Barbara holds an MBA from The Wharton School and a BS in Accounting from Louisiana State University.